Lisata Therapeutics

LSTA · NASDAQ

$1.04+$0.04 (+4.00%)TodayMarket closed · Oct 20, 6:12 PM ET

Prev close $1.00

Latest news

Press releaseOct 3, 6:38 PM ETPRNewswire
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA
NewsSep 17, 2:09 PM ETVandana Singh
Nano Cap Lisata Therapeutics Bolsters Cardioendocrine Pipeline Strategy
NewsSep 17, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsAug 21, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseAug 4, 7:00 AM ETGlobe Newswire
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
NewsJul 22, 1:03 AM ETTanya Rawat
Lisata Therapeutics Stock Falls After Hours: Here's Why
Press releaseJun 16, 9:00 AM ETPRNewswire
Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders?
Press releaseJun 10, 8:00 AM ETGlobe Newswire
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
NewsMay 29, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseMay 14, 5:22 PM ETPRNewswire
Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?
Press releaseMar 9, 7:00 AM ETPRNewswire
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Press releaseMar 6, 6:15 PM ETGlobe Newswire
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Press releaseFeb 11, 8:51 PM ETPRNewswire
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Press releaseFeb 11, 8:02 PM ETPRNewswire
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Press releaseJan 28, 6:41 PM ETPRNewswire
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Press releaseJan 28, 2:23 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
NewsJan 27, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseJan 27, 8:00 AM ETGlobe Newswire
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Press releaseJan 21, 2:46 PM ETBusiness Wire
LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders
NewsJan 21, 12:15 PM ETAvi Kapoor
Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates
NewsJan 21, 10:31 AM ETNabaparna Bhattacharya
Why Is Lisata Therapeutics Stock Gaining Today?
NewsJan 21, 10:05 AM ETAvi Kapoor
Dow Surges 300 Points; Netflix Shares Fall After Q4 Results
Press releaseNov 6, 4:05 PM ETGlobe Newswire
Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Press releaseNov 6, 8:00 AM ETGlobe Newswire
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for 'Overall BioPharma Solution of the Year'
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsNov 4, 4:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseNov 4, 4:00 PM ETGlobe Newswire
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
Press releaseOct 30, 8:00 AM ETGlobe Newswire
Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
Press releaseOct 8, 8:30 AM ETGlobe Newswire
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
Press releaseSep 29, 8:00 AM ETGlobe Newswire
Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial
Press releaseAug 7, 4:05 PM ETGlobe Newswire
Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
NewsAug 7, 4:33 AM ET
Earnings Scheduled For August 7, 2025
Press releaseJul 31, 8:00 AM ETGlobe Newswire
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
Press releaseMay 8, 4:05 PM ETGlobe Newswire
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
NewsMay 8, 4:33 AM ET
Earnings Scheduled For May 8, 2025
Press releaseMay 1, 8:00 AM ETGlobe Newswire
Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
Press releaseFeb 27, 4:05 PM ETGlobe Newswire
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Press releaseFeb 20, 8:00 AM ETGlobe Newswire
Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025
NewsJan 22, 2:39 PM ETAvi Kapoor
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
NewsJan 22, 11:59 AM ETAvi Kapoor
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
NewsJan 22, 9:45 AM ETAvi Kapoor
US Stocks Higher; Netflix Profit Beats Estimates
NewsJan 22, 4:58 AM ETAvi Kapoor
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA

Nano Cap Lisata Therapeutics Bolsters Cardioendocrine Pipeline Strategy

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Lisata Therapeutics Stock Falls After Hours: Here's Why

Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders?

Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.

12 Health Care Stocks Moving In Friday's After-Market Session

Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?

Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.

Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?

Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA

12 Health Care Stocks Moving In Tuesday's Intraday Session

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders

Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates

Why Is Lisata Therapeutics Stock Gaining Today?

Dow Surges 300 Points; Netflix Shares Fall After Q4 Results

Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for 'Overall BioPharma Solution of the Year'

Earnings Scheduled For November 6, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session

Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025

Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement

Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial

Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For August 7, 2025

Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For May 8, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings

US Stocks Higher; Netflix Profit Beats Estimates

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket